Sign in
FNCHQ Stock Price, Chart, Stats & News
Finch Therapeutics Group, Inc.
Save
Finch Therapeutics Group, Inc. (FNCHQ) does not currently pay a dividend.
16.22M
Market cap
–
Current P/E
–
Forward P/E
FNCHQ chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Similar securities
Based on sector and market capitalization
Report issue